Haloperidol for the treatment of delirium in critically ill patients: an updated systematic review with meta-analysis and trial sequential analysis

BACKGROUND: Haloperidol is frequently used in critically ill patients with delirium, but evidence for its effects has been sparse and inconclusive. By including recent trials, we updated a systematic review assessing effects of haloperidol on mortality and serious adverse events in critically ill pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen-Ranberg, Nina Christine, Barbateskovic, Marija, Perner, Anders, Oxenbøll Collet, Marie, Musaeus Poulsen, Lone, van der Jagt, Mathieu, Smit, Lisa, Wetterslev, Jørn, Mathiesen, Ole, Maagaard, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463604/
https://www.ncbi.nlm.nih.gov/pubmed/37633991
http://dx.doi.org/10.1186/s13054-023-04621-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463604/
https://www.ncbi.nlm.nih.gov/pubmed/37633991
http://dx.doi.org/10.1186/s13054-023-04621-4

Ejemplares similares